Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease
Spectranetics Corporation today announced that it plans to initiate the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial ...
A group of California doctors stopped enrolling new patients last week in a clinical trial using Spectranetics Corp. medical lasers after federal regulators raised safety concerns about the lasers, ...
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Excimer laser procedure to be tested on more than 350 patients. COLORADO SPRINGS, Colo.--(BUSINESS WIRE)-- Spectranetics Corporation (Nasdaq:SPNC - News) today announced that it plans to initiate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback